112 related articles for article (PubMed ID: 14646624)
21. Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein.
Yamada K; Jimbow K
Melanoma Res; 1992 Nov; 2(4):225-33. PubMed ID: 1490110
[TBL] [Abstract][Full Text] [Related]
22. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Alena F; Iwashina T; Gili A; Jimbow K
Cancer Res; 1994 May; 54(10):2661-6. PubMed ID: 8168094
[TBL] [Abstract][Full Text] [Related]
23. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models.
Ito S; Nishigaki A; Ishii-Osai Y; Ojika M; Wakamatsu K; Yamashita T; Tamura Y; Ito A; Honda H; Nakayama E; Jimbow K
Biochem Pharmacol; 2012 Sep; 84(5):646-53. PubMed ID: 22728921
[TBL] [Abstract][Full Text] [Related]
25. In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.
Kitagawa M; Nemoto T; Seki S; Ito S; Kasuga T
J Cancer Res Clin Oncol; 1993; 119(8):470-4. PubMed ID: 8099588
[TBL] [Abstract][Full Text] [Related]
26. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-melanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol substituted with two methyl groups alpha to the nitrogen.
Lant NJ; McKeown P; Timoney MC; Kelland LR; Rogers PM; Robins DJ
Anticancer Drug Des; 2001 Feb; 16(1):49-55. PubMed ID: 11762644
[TBL] [Abstract][Full Text] [Related]
28. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
Ito Y; Jimbow K
Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
[TBL] [Abstract][Full Text] [Related]
29. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
Prezioso JA; Damodaran KM; Wang N; Bloomer WD
Biochem Pharmacol; 1993 Jan; 45(2):473-81. PubMed ID: 8435097
[TBL] [Abstract][Full Text] [Related]
30. Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma.
Jimbow K; Miura T; Ito S; Ishikawa K
Pigment Cell Res; 1989; 2(1):34-9. PubMed ID: 2717528
[TBL] [Abstract][Full Text] [Related]
31. The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines.
Yamada I; Seki S; Ito S; Suzuki S; Matsubara O; Kasuga T
Br J Cancer; 1991 Feb; 63(2):187-90. PubMed ID: 1997095
[TBL] [Abstract][Full Text] [Related]
32. The synthesis of N-acetyl-4-S-cysteaminyl [U-14C]phenol as a basis for the development of an antimelanoma and melanoma-radioimaging agent.
Iwashina T; Jimbow K; Wiebe LI
Appl Radiat Isot; 1994 Jun; 45(6):703-5. PubMed ID: 8038763
[TBL] [Abstract][Full Text] [Related]
33. A Sulfur Containing Melanogenesis Substrate,
Tamura Y; Ito A; Wakamatsu K; Torigoe T; Honda H; Ito S; Jimbow K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982309
[No Abstract] [Full Text] [Related]
34. Synthesis and antimelanoma activity of tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Pearson VC; Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2003; 13(11):503-12. PubMed ID: 12812364
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect.
Miura S; Ueda T; Jimbow K; Ito S; Fujita K
Arch Dermatol Res; 1987; 279(4):219-25. PubMed ID: 3674957
[TBL] [Abstract][Full Text] [Related]
36. N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.
Ishii-Osai Y; Yamashita T; Tamura Y; Sato N; Ito A; Honda H; Wakamatsu K; Ito S; Nakayama E; Okura M; Jimbow K
J Dermatol Sci; 2012 Jul; 67(1):51-60. PubMed ID: 22622238
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol.
Lant NJ; McKeown P; Kelland LR; Rogers PM; Robins DJ
Anticancer Drug Des; 2000 Aug; 15(4):295-302. PubMed ID: 11200505
[TBL] [Abstract][Full Text] [Related]
38. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
[TBL] [Abstract][Full Text] [Related]
39. Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells.
Yamada K; Jimbow K; Engelhardt R; Ito S
Biochem Pharmacol; 1989 Jul; 38(13):2217-21. PubMed ID: 2735958
[No Abstract] [Full Text] [Related]
40. Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.
Vad NM; Kandala PK; Srivastava SK; Moridani MY
Chem Biol Interact; 2010 Feb; 183(3):462-71. PubMed ID: 19944085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
